Ushbu ish iqtibos qilgan ishlar

27 ta ish

Ish: Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan

1. Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis

   Armand Van Deun, Aung Kya Jai Maug, Md Abdul Hamid Salim +4

   Maqola201011 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.027992

2. Global tuberculosis report (2014)

   L.A. Gabbasova, E.R. Experts Who

   Maqola20148 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.105443

3. A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

   Andrew Nunn, Patrick Phillips, Sarah Meredith +16

   Maqola20196 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.006848

4. High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses

   Alberto Piubello, Souleymane Hassane Harouna, Mahamadou Bassirou Souleymane +5

   Maqola20146 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.027986

5. High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon

   Christopher Kuaban, J Noeske, Hans L. Rieder +3

   Maqola20155 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.027995

6. Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives

   Emanuele Pontali, Mario Raviǵlione, Giovanni Battista Migliori

   Sharh maqola20195 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.133230

7. The Discovery of Grounded Theory; Strategies for Qualitative Research

   Barney G. Glaser, Anselm L. Strauss, Elizabeth Strutzel

   Maqola19685 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.522261

8. Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

   Shona Horter, Beverley Stringer, Jane Greig +5

   MaqolaTuberculosis Research and EpidemiologyBMC Infectious Diseases20164 iqtibos

   ABIABI:AkademIndex/openalex/2016.article.000054

9. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

   Faiz Ahmad Khan, M Salim, Philipp du Cros +9

   Sharh maqolaTuberculosis Research and EpidemiologyEuropean Respiratory Journal20174 iqtibos

   ABIABI:AkademIndex/openalex/2017.review-article.000004

10. Principles for designing future regimens for multidrug-resistant tuberculosis

    Grania Brigden, Bern-Thomas Nyang’wa, Philipp du Cros +9

    Maqola20133 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.006845

11. “When Treatment Is More Challenging than the Disease”: A Qualitative Study of MDR-TB Patient Retention

    Kalpita Shringarpure, Petros Isaakidis, Karuna D. Sagili +3

    Maqola20163 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.360271

12. The Discovery of Grounded Theory: Strategies for Qualitative Research.

    Helmut R. Wagner, Barney G. Glaser, Anselm L. Strauss

    Maqola19683 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.569246

13. ‘They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan

    Beverley Stringer, Karen Lowton, Mirzagaleb N. Tillashaikhov +5

    MaqolaTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20162 iqtibos

    ABIABI:AkademIndex/openalex/2016.article.000087

14. Recent controversies about <scp>MDR</scp> and <scp>XDR‐TB</scp>: <scp>G</scp>lobal implementation of the <scp>WHO</scp> shorter <scp>MDR‐TB</scp> regimen and bedaquiline for all with <scp>MDR‐TB</scp>?

    Keertan Dheda, Helen Cox, Aliasgar Esmail +3

    Sharh maqola20172 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.130259

15. Sampling for qualitative research

    Martin Marshall

    Maqola19962 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.184186

16. Impact of patient and program factors on default during treatment of multidrug-resistant tuberculosis

    Ma Tarcela Gler, Laura Jean Podewils, N. Munez +3

    Maqola20122 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.184195

17. Rethinking the patient: using Burden of Treatment Theory to understand the changing dynamics of illness

    Carl May, David T. Eton, Kasey R. Boehmer +9

    Maqola20142 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.245437

18. Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies

    Simon Tiberi, Nelita du Plessis, Gerhard Walzl +11

    Sharh maqola20182 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.360228

19. New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis

    Denise Rossato Silva, Margareth Pretti Dalcolmo, Simon Tiberi +9

    Sharh maqola20182 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.360229

20. Applicability of the shorter ‘Bangladesh regimen’ in high multidrug-resistant tuberculosis settings

    Giovanni Sotgiu, Simon Tiberi, Rosella Centis +4

    Maqola20162 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.360273

21. Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe

    Christoph Lange, Raquel Duarte, M. Jachym +7

    Boshqa20162 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.363668

22. Psycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic Review

    Beena Thomas, Poonguzhali Shanmugam, Malaisamy Muniyandi +5

    Sharh maqola20162 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.569244

23. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.569242

24. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.569243

25. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.569245